BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:27 PM
 | 
Apr 19, 2010
 |  BC Extra  |  Politics & Policy

FDA reviewing safety decision-making

FDA Commissioner Margaret Hamburg has ordered an internal review of the agency's processes for making drug safety decisions, and has separately asked the Institute of Medicine to study and make recommendations about scientific and ethical issues associated with drug safety research. The two initiatives were described in a...

Read the full 219 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >